| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Thursday, May 08, 2025 8:15:22 AM
Since End story soon, so LP doesn't need hire new blood, no need marketing team, salesteam, no need hire new staff for accounting, no need new CFO. In fact, they can't handle heavy workload after MHRA approval. I am guessing LP has the Offer already, just waiting MHRA approval, then announce the big news
In theory yes, but in practice perhaps not.
Unfortunately there are many leaders out there in business and government who cannot do the job themselves anymore (if they ever could) but who refuse out of ego or greed to give up power or at least share power with those who can and this holds back progress in ways we cannot begin to calculate. Look at how long the last US President clung to power and by the time he stepped aside it was too late for his replacement as candidate to gain traction. He refused to recognize that one might manage being a candidate with that degree of infirmity or a caretaker president but not both simultaneously and clung to both roles way too long.
If NWBO gets MHRA approval then things are about to get a lot harder.
I believe this management team probably honestly believes the propaganda of their supporters and sees the dismal failure to make progress on a reasonable timeframe let along deliver value to shareholders as a great success and that under any leadership team that this would have failed.
It is pretty clear that the lack of separate CFO is a feature and not a flaw and thus not an indicator they are just passing time until a buyout.
The Woodford debacle shows how much pain management was willing to have shareholders accept rather than to share power with others let alone give it all up entirely.
Remember the infamous phrase ‘All Big Pharma brings to the table is a checkbook.’
Unless that bad attitude has changed, do not confuse your desire for this to be over and actually derisked with what management might or might not see as necessary. Remember that their interests and ours are not in full alignment, they are already rich while we are not and so waiting means something much different to them than it does to us.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
